AEON Biopharma Inc.

AEON | AMEX

Price Alert Chart Builder DCF Calculator

$0.48

-$0.02 (-4.52%)

Jul 10, 2026, 3:58 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $5.95M

Enterprise Value $2.1M

Beta 0.61

Average Volume 78.02K

Shares Outstanding (Diluted) 12.11M

Shares Change YoY 203.8%

Institutional Ownership 28.64%

Exchange AMEX

ISIN US00791X2099

Price Performance

Price Change 1M -34.7%

Price Change 3M -42.5%

Price Change 6M -56.1%

Price Change YTD -56.5%

Price Change 1Y -40.9%

Price Change 3Y -99.9%

Price Change 5Y -99.9%

1M CAGR (ann.) -14.7%

1Y CAGR (ann.) -16.4%

5Y CAGR (ann.) N/A

All-Time CAGR -90.2%

Valuation

PE Ratio -0.10

Forward PE N/A

PEG Ratio 0.00

Forward PEG N/A

PS Ratio N/A

Forward PS 2.40

PB Ratio -0.34

P/FCF Ratio -0.47

P/Adj. FCF Ratio -0.33

P/OCF Ratio -0.48

EV/Sales N/A

EV/EBIT -0.09

EV/EBITDA -0.09

EV/FCF -0.17

Earnings Yield -1047.9%

FCF Yield -210.6%

Adj. FCF Yield -307.2%

Financial Health

Net Cash $4.7M

Total Debt $2.63M

Cash & Short-Term Investments $6.24M

Total Assets $8.63M

Current Ratio 0.99

Quick Ratio 0.99

Debt / Equity Ratio -0.16

Debt / EBITDA -0.11

Debt / FCF -0.22

OCF / Debt -4.58

Interest Coverage 0.00

Altman Z-Score -87.39

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -45.9%

Returns

Return on Assets -696.5%

Return on Equity 223.7%

Return on Invested Capital -823.8%

Return on Capital Employed -932.1%

Return on Tangible Assets -696.5%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -20.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 28.5%

EPS CAGR 5Y 19.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y 17.3%

FCF CAGR 5Y -16.6%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating N/A

Analyst Count N/A

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Aug 10, 2026

EPS Estimate (next Q) -$0.33

EPS Growth Est (next Q) -45.0%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-12.04M

Free Cash Flow $-12.04M

Adj. Free Cash Flow $-17.56M

FCF Per Share -$0.99

OCF Per Share -$0.99

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-19K

Operating Income $-18.28M

EBITDA $-24.07M

Net Income $-60.11M

EPS (Diluted) -$5.03

Revenue / Employee N/A

Profit / Employee $-12.02M

Employees 5